Changes in respiratory muscle function after neostigmine injection in patients with myasthenia gravis.
In sixteen patients with myasthenia gravis, the weakness of respiratory muscles, especially of expiratory, caused some disturbances in lung function. Thirty minutes after injection of neostigmine, general improvement of muscle function was accompanied by an increase of strength and endurance of respiratory muscles. The mean value of maximal inspiratory mouth pressure (PImax) increased by 33%, maximal expiratory mouth pressure (PEmax) by 23.5% and maximal voluntary ventilation (MVV) by 21%. As a consequence of these changes amelioration of lung function indices was found, vital capacity increasing on average by 13% and residual volume decreasing by 12.5%. We concluded that patients with generalized myasthenia gravis have disturbances in lung function which may be partially improved by neostigmine injection or other anticholinesterase agents.
Radwan
L
L
Institute of Tuberculosis and Chest Diseases, Medical Academy, Warszawa, Poland.
Strugalska
M
M
Koziorowski
A
A
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008451:Maximal Voluntary Ventilation; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000503:physiopathology*; D009388:Neostigmine / Q000494:pharmacology*; D012123:Pulmonary Ventilation; D012115:Residual Volume; D012129:Respiratory Function Tests; D012132:Respiratory Muscles / Q000187:drug effects / Q000503:physiopathology*; D014109:Total Lung Capacity; D014797:Vital Capacity
D009388:Neostigmine